These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 21160499)

  • 1. Agminated segmental nevi demonstrating intranevic concordance of BRAF status.
    Luo S; Chaplin AC; Langley RG; Njauw CN; Duncan LM; Miller RA; Tsao H
    J Invest Dermatol; 2011 Mar; 131(3):788-90. PubMed ID: 21160499
    [No Abstract]   [Full Text] [Related]  

  • 2. The dermoscopical and histopathological patterns of nevi correlate with the frequency of BRAF mutations.
    Zalaudek I; Guelly C; Pellacani G; Hofmann-Wellenhof R; Trajanoski S; Kittler H; Scope A; Marghoob AA; Longo C; Leinweber B; Ferrara G; Saida T; Grichnik JM; Argenziano G; Becker JC
    J Invest Dermatol; 2011 Feb; 131(2):542-5. PubMed ID: 21068756
    [No Abstract]   [Full Text] [Related]  

  • 3. Eruptive agminated nevi in a successfully treated Langerhans cell histiocytosis patient.
    Echavarria M; Schoch J; Tate J; Motaparthi K; De Benedetto A; Reith J; Howell D
    Pediatr Dermatol; 2021 Jul; 38(4):879-882. PubMed ID: 34227145
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Benign nodal nevi frequently harbor the activating V600E BRAF mutation.
    Taube JM; Begum S; Shi C; Eshleman JR; Westra WH
    Am J Surg Pathol; 2009 Apr; 33(4):568-71. PubMed ID: 19033861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High frequency of BRAFV600E mutation in acquired nevi and small congenital nevi, but low frequency of mutation in medium-sized congenital nevi.
    Ichii-Nakato N; Takata M; Takayanagi S; Takashima S; Lin J; Murata H; Fujimoto A; Hatta N; Saida T
    J Invest Dermatol; 2006 Sep; 126(9):2111-8. PubMed ID: 16691193
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BRAF V600E Mutations in Nevi and Melanocytic Tumors of Uncertain Malignant Potential.
    Seitz-Alghrouz R; Hidalgo JV; Kayser C; Kreutz C; Technau-Hafsi K; Diaz C; von Deimling A; Timmer J; Werner M; Malkovsky M; Fisch P
    J Invest Dermatol; 2018 Nov; 138(11):2489-2491. PubMed ID: 29775633
    [No Abstract]   [Full Text] [Related]  

  • 7. BRAFV600E mutation status of involuting and stable nevi in dabrafenib therapy with or without trametinib.
    McClenahan P; Lin LL; Tan JM; Flewell-Smith R; Schaider H; Jagirdar K; Atkinson V; Lambie D; Prow TW; Sturm RA; Soyer HP
    JAMA Dermatol; 2014 Oct; 150(10):1079-82. PubMed ID: 24695877
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distribution of BRAF T1799A(V600E) mutations across various types of benign nevi: implications for melanocytic tumorigenesis.
    Wu J; Rosenbaum E; Begum S; Westra WH
    Am J Dermatopathol; 2007 Dec; 29(6):534-7. PubMed ID: 18032947
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of the BRAF V600E mutation in melanocytic lesions using the ligase detection reaction.
    Turner DJ; Zirvi MA; Barany F; Elenitsas R; Seykora J
    J Cutan Pathol; 2005 May; 32(5):334-9. PubMed ID: 15811117
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improving classification of melanocytic nevi: Association of BRAF V600E expression with distinct histomorphologic features.
    Kiuru M; Tartar DM; Qi L; Chen D; Yu L; Konia T; McPherson JD; Murphy WJ; Fung MA
    J Am Acad Dermatol; 2018 Aug; 79(2):221-229. PubMed ID: 29653212
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BRAF V600E Mutation in Involuting Nevus in a Patient Treated With Vemurafenib.
    Millán-Cayetano JF; Fernández-Canedo I; Blázquez-Sánchez N; Fúnez-Liébana R; de Troya-Martín M
    JAMA Dermatol; 2017 Jun; 153(6):605-607. PubMed ID: 28249088
    [No Abstract]   [Full Text] [Related]  

  • 12. Predictors of BRAF mutation in melanocytic nevi: analysis across regions with different UV radiation exposure.
    Karram S; Novy M; Saroufim M; Loya A; Taraif S; Houreih MA; Rauscher B; Habib RH; Oberkanins C; Khalifeh I
    Am J Dermatopathol; 2013 Jun; 35(4):412-8. PubMed ID: 23051629
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BRAF mutations are sufficient to promote nevi formation and cooperate with p53 in the genesis of melanoma.
    Patton EE; Widlund HR; Kutok JL; Kopani KR; Amatruda JF; Murphey RD; Berghmans S; Mayhall EA; Traver D; Fletcher CD; Aster JC; Granter SR; Look AT; Lee C; Fisher DE; Zon LI
    Curr Biol; 2005 Feb; 15(3):249-54. PubMed ID: 15694309
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CDKN2B Loss Promotes Progression from Benign Melanocytic Nevus to Melanoma.
    McNeal AS; Liu K; Nakhate V; Natale CA; Duperret EK; Capell BC; Dentchev T; Berger SL; Herlyn M; Seykora JT; Ridky TW
    Cancer Discov; 2015 Oct; 5(10):1072-85. PubMed ID: 26183406
    [TBL] [Abstract][Full Text] [Related]  

  • 15. What dermoscopy tells us about nevogenesis.
    Zalaudek I; Catricalà C; Moscarella E; Argenziano G
    J Dermatol; 2011 Jan; 38(1):16-24. PubMed ID: 21175751
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Melanocytic nevi excised during B-Raf proto-oncogene (BRAF) inhibitor therapy: A study of 19 lesions from 10 patients.
    Mochel MC; Hammond MR; Frederick DT; Alora-Palli MB; Piris A; Flaherty KT; Hoang MP
    J Am Acad Dermatol; 2015 Sep; 73(3):491-9.e2. PubMed ID: 26190239
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Melanocytic nevus-like hyperplasia and melanoma in transgenic BRAFV600E mice.
    Goel VK; Ibrahim N; Jiang G; Singhal M; Fee S; Flotte T; Westmoreland S; Haluska FS; Hinds PW; Haluska FG
    Oncogene; 2009 Jun; 28(23):2289-98. PubMed ID: 19398955
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutations of the BRAF gene in benign and malignant melanocytic lesions.
    Yazdi AS; Palmedo G; Flaig MJ; Puchta U; Reckwerth A; Rütten A; Mentzel T; Hügel H; Hantschke M; Schmid-Wendtner MH; Kutzner H; Sander CA
    J Invest Dermatol; 2003 Nov; 121(5):1160-2. PubMed ID: 14708620
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BRAF analysis on a spectrum of melanocytic neoplasms: an epidemiological study across differing UV regions.
    Saroufim M; Habib R; Karram S; Youssef Massad C; Taraif S; Loya A; Houreih MA; Sheikh SS; Amr SS; Satti M; Oberkanins C; Khalifeh I
    Am J Dermatopathol; 2014 Jan; 36(1):68-73. PubMed ID: 23782679
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BRAF mutations in melanocytic tumors (nevi and melanomas) from organ transplant recipients.
    Kanitakis J; Baldassini S; Lora V; Euvrard S
    Eur J Dermatol; 2010; 20(2):167-71. PubMed ID: 19919912
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.